3-((2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)-propyl monophosphate

ID: ALA574076

Chembl Id: CHEMBL574076

PubChem CID: 45481632

Max Phase: Preclinical

Molecular Formula: C8H13N2O7P

Molecular Weight: 280.17

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1ccn(COCCCOP(=O)(O)O)c(=O)[nH]1

Standard InChI:  InChI=1S/C8H13N2O7P/c11-7-2-3-10(8(12)9-7)6-16-4-1-5-17-18(13,14)15/h2-3H,1,4-6H2,(H,9,11,12)(H2,13,14,15)

Standard InChI Key:  DEVQYDPJVBYSLJ-UHFFFAOYSA-N

Associated Targets(non-human)

P2ry2 Purinergic receptor P2Y2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 280.17Molecular Weight (Monoisotopic): 280.0460AlogP: -0.99#Rotatable Bonds: 7
Polar Surface Area: 130.85Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 1.73CX Basic pKa: CX LogP: -1.32CX LogD: -4.43
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.43Np Likeness Score: 0.07

References

1. Sauer R, El-Tayeb A, Kaulich M, Müller CE..  (2009)  Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.,  17  (14): [PMID:19523835] [10.1016/j.bmc.2009.05.062]

Source